Table 2 Bivariate analyses between observed variables and 28-day mortality
From: Gut microbiome dynamics and associations with mortality in critically ill patients
Median[IQR] or n | Death < 28 days | Death > 28 days | P value | |
|---|---|---|---|---|
Sex (male) | 24 (46%) | 11 (21%) | 13 (25%) | 0.4 |
APACHE II score | 27.0 [ 21.0, 32.2] | 31.0 [25.8, 35.0] | 24.5 [ 20.0, 28.8] | 0.012 |
ARDS | 26 (50%) | 19 (37%) | 7 (13%) | 0.012 |
Malignancy | 13 (25%) | 10 (19%) | 3 (6%) | 0.064 |
Immunosuppressed | 20 (38%) | 13 (25%) | 7 (13%) | 0.26 |
Diabetes | 18 (35%) | 11 (21%) | 7 (13%) | 0.56 |
Sepsis-3 | 34 (65%) | 19 (37%) | 15 (29%) | 0.77 |
Vancomycin | 28 (54%) | 18 (35%) | 10 (19%) | 0.16 |
Ceftriaxone | 14 (27%) | 6 (12%) | 8 (15%) | 0.37 |
Ciprofloxacin | 12 (23%) | 8 (15%) | 4 (8%) | 0.35 |
Piperacillin-tazobactam | 31 (60%) | 19 (37%) | 12 (23%) | 0.26 |
MMI | 0.3 [-0.2, 1.3] | 0.9 [0.0, 1.7] | -0.1 [-0.7, 0.6] | 0.01 |
MMI > 0 | 31 (60%) | 21 (40%) | 10 (19%) | 0.023 |
Shannon (D) | 5.8 [ 4.7, 6.2] | 5.8 [ 4.7, 6.2] | 5.9 [ 4.7, 6.2] | 1.0 |
Chao1 (R) | 102.0 [ 76.5, 133.2] | 102.0 [ 76.5, 127.5] | 99.5 [ 77.8, 144.8] | 0.71 |